Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma. - Robatel S; Hillen H; Mutisheva I; Müller JC; Wartenberg M; Ma F; Bäriswyl L; Evenepoel J; Scheele CLGJ; Lee DJ; Modlin RL; Kessler U; et al. (Journal of gastroenterology, 2026)